Bronchoalveolar Cell Lung Cancer Completed Phase 2 / 3 Trials for Paclitaxel (DB01229)

IndicationStatusPhase
DBCOND0028477 (Bronchoalveolar Cell Lung Cancer)Completed2 / 3
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT00021060Combination Chemotherapy With or Without Bevacizumab in Treating Patients With Advanced, Metastatic, or Recurrent Non-Small Cell Lung CancerTreatment